检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张羽[1] 杨海超[1] 董天秀[1] 李甜甜[2] 王琦[3] 杨秀华[1]
机构地区:[1]哈尔滨医科大学附属第一医院腹部超声科,150001 [2]齐齐哈尔市第一医院超声科 [3]大庆油田总医院超声科
出 处:《肝脏》2015年第5期343-346,共4页Chinese Hepatology
基 金:国家自然科学基金面上项目(81171346);黑龙江省教育厅科学技术研究面上项目(12511327)
摘 要:目的研究肝细胞癌患者免疫抑制性Treg细胞对CD8+T淋巴细胞穿孔素表达的影响。方法采集20例肝细胞癌患者和20名健康人的外周血,用流式分析法检测抗-CD3/CD28刺激48 h后CD8+T淋巴细胞的穿孔素表达情况。免疫磁珠分离法分离健康人CD8+T淋巴细胞和肝细胞癌患者Treg细胞,一组CD8+T淋巴细胞单独培养,另一组CD8+T淋巴细胞与Treg细胞共同培养,用流式细胞法检测抗-CD3/CD28刺激48 h后两组CD8+T淋巴细胞穿孔素表达情况。结果肝细胞癌患者外周血中CD8+T淋巴细胞穿孔素表达量与健康人相近,分别为(10.74±3.96)%和(12.6±2.48)%,差异无统计学意义(P>0.05)。CD8+T淋巴细胞单独培养和与肝癌患者Treg细胞共培养后,健康人CD8+T淋巴细胞穿孔素表达量分别为(34.2±3.65)%和(20.43±4.52)%,差异有统计学意义(t=11.42,P<0.01)。结论肝癌患者免疫抑制性Treg细胞可使CD8+T淋巴细胞穿孔素表达量降低。Objective To investigate the influence of immunosuppressive regulatory T cells (Treg)in patients with hepatocellular carcinoma (HCC)on perforin expression of CD8 + T lymphocytes.Methods Perforin expression of CD8 + T lymphocytes in 20 healthy subjects and 20 HCC patients was detected by flow cytometry.CD8 + T lymphocytes from 20 healthy subjects and Treg from 20 HCC patients were collected by magnetic activated cell sorting (MACS),then were divided into two groups:single culture of CD8 + T lymphocytes and co-culture of CD8 + T lymphocytes and Treg.Both groups were stimulated by anti-CD3/CD28 for 48 hours.Perforin expressions of CD8 + T lymphocytes in both groups were quantitatively detected by flow cytometry.Results Perforin expression of CD8 + T lymphocytes in HCC patients (10.74%&±3.96%)was similar with that in healthy subjects (12.6% &±2.48%)(P 〉0.05 ).However,perforin expression was significantly decreased after CD8 + T lymphocytes were co-cultured with Treg [(34.2%&±3.65%)and (20.43%&±4.52%), respectively (P 〈0.01)].Conclusion Treg could significantly reduce perforin expression of CD8 + T lymphocytes.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3